IBDEI09I ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4387,2)
 ;;=^267298
 ;;^UTILITY(U,$J,358.3,4388,0)
 ;;=255.10^^37^427^3
 ;;^UTILITY(U,$J,358.3,4388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4388,1,3,0)
 ;;=3^255.10
 ;;^UTILITY(U,$J,358.3,4388,1,4,0)
 ;;=4^ALDOSTERONISM
 ;;^UTILITY(U,$J,358.3,4388,2)
 ;;=^330019
 ;;^UTILITY(U,$J,358.3,4389,0)
 ;;=255.0^^37^427^4
 ;;^UTILITY(U,$J,358.3,4389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4389,1,3,0)
 ;;=3^255.0
 ;;^UTILITY(U,$J,358.3,4389,1,4,0)
 ;;=4^CUSHING'S SYNDROME
 ;;^UTILITY(U,$J,358.3,4389,2)
 ;;=^29802
 ;;^UTILITY(U,$J,358.3,4390,0)
 ;;=403.90^^37^427^6
 ;;^UTILITY(U,$J,358.3,4390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4390,1,3,0)
 ;;=3^403.90
 ;;^UTILITY(U,$J,358.3,4390,1,4,0)
 ;;=4^HTN RENAL w/o RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,4390,2)
 ;;=^334272
 ;;^UTILITY(U,$J,358.3,4391,0)
 ;;=403.91^^37^427^5
 ;;^UTILITY(U,$J,358.3,4391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4391,1,3,0)
 ;;=3^403.91
 ;;^UTILITY(U,$J,358.3,4391,1,4,0)
 ;;=4^HTN RENAL w/ RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,4391,2)
 ;;=^334242
 ;;^UTILITY(U,$J,358.3,4392,0)
 ;;=405.91^^37^427^7
 ;;^UTILITY(U,$J,358.3,4392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4392,1,3,0)
 ;;=3^405.91
 ;;^UTILITY(U,$J,358.3,4392,1,4,0)
 ;;=4^HTN RENOVASCULAR NOS
 ;;^UTILITY(U,$J,358.3,4392,2)
 ;;=^269634
 ;;^UTILITY(U,$J,358.3,4393,0)
 ;;=403.00^^37^427^9
 ;;^UTILITY(U,$J,358.3,4393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4393,1,3,0)
 ;;=3^403.00
 ;;^UTILITY(U,$J,358.3,4393,1,4,0)
 ;;=4^MAL HTN RENAL w/o RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,4393,2)
 ;;=^334270
 ;;^UTILITY(U,$J,358.3,4394,0)
 ;;=403.01^^37^427^8
 ;;^UTILITY(U,$J,358.3,4394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4394,1,3,0)
 ;;=3^403.01
 ;;^UTILITY(U,$J,358.3,4394,1,4,0)
 ;;=4^MAL HTN RENAL w/ RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,4394,2)
 ;;=^334240
 ;;^UTILITY(U,$J,358.3,4395,0)
 ;;=405.01^^37^427^10
 ;;^UTILITY(U,$J,358.3,4395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4395,1,3,0)
 ;;=3^405.01
 ;;^UTILITY(U,$J,358.3,4395,1,4,0)
 ;;=4^MAL HTN RENOVASCULAR
 ;;^UTILITY(U,$J,358.3,4395,2)
 ;;=^269628
 ;;^UTILITY(U,$J,358.3,4396,0)
 ;;=404.91^^37^428^1
 ;;^UTILITY(U,$J,358.3,4396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4396,1,3,0)
 ;;=3^404.91
 ;;^UTILITY(U,$J,358.3,4396,1,4,0)
 ;;=4^HTN HRT/REN w/ CHF,NOS
 ;;^UTILITY(U,$J,358.3,4396,2)
 ;;=^334249
 ;;^UTILITY(U,$J,358.3,4397,0)
 ;;=404.93^^37^428^2
 ;;^UTILITY(U,$J,358.3,4397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4397,1,3,0)
 ;;=3^404.93
 ;;^UTILITY(U,$J,358.3,4397,1,4,0)
 ;;=4^HTN HRT/REN w/ CHR&RF,NOS
 ;;^UTILITY(U,$J,358.3,4397,2)
 ;;=^334251
 ;;^UTILITY(U,$J,358.3,4398,0)
 ;;=404.90^^37^428^4
 ;;^UTILITY(U,$J,358.3,4398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4398,1,3,0)
 ;;=3^404.90
 ;;^UTILITY(U,$J,358.3,4398,1,4,0)
 ;;=4^HTN HRT/REN w/o CHF/RF,NOS
 ;;^UTILITY(U,$J,358.3,4398,2)
 ;;=^334275
 ;;^UTILITY(U,$J,358.3,4399,0)
 ;;=404.92^^37^428^3
 ;;^UTILITY(U,$J,358.3,4399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4399,1,3,0)
 ;;=3^404.92
 ;;^UTILITY(U,$J,358.3,4399,1,4,0)
 ;;=4^HTN HRT/REN w/ RENAL FAILURE,NOS
 ;;^UTILITY(U,$J,358.3,4399,2)
 ;;=^334250
 ;;^UTILITY(U,$J,358.3,4400,0)
 ;;=404.01^^37^428^5
 ;;^UTILITY(U,$J,358.3,4400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4400,1,3,0)
 ;;=3^404.01
 ;;^UTILITY(U,$J,358.3,4400,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ CHF
 ;;^UTILITY(U,$J,358.3,4400,2)
 ;;=^334243
 ;;^UTILITY(U,$J,358.3,4401,0)
 ;;=404.03^^37^428^6
 ;;^UTILITY(U,$J,358.3,4401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4401,1,3,0)
 ;;=3^404.03
